The Nutrion breath acetone analyzer is operated via a smartphone app and allows the self-monitoring of breath acetone as a biomarker for fat metabolism. (Credit: Alivion AG)
Forget Blood Tests: This Breathalyzer Tracks Ketones in Real Time
In A Nutshell
- A handheld, smartphone-connected device measures acetone in breath, a byproduct linked to the body’s ketone production and shift toward burning fat.
- Tested on 312 breath samples from 12 healthy adults, its readings matched closely and consistently with a high-end lab mass spectrometer.
- Breath acetone rose sharply during fasting, high-intensity exercise, and ketogenic eating, then dropped after carb-rich meals, though the size of the change varied a lot between people.
- The study measured device accuracy only; it did not test whether using it changes weight, athletic performance, or diabetes management.
Checking whether the body has shifted into fat-burning mode could soon be as simple as blowing into a device the size of a small remote control. No needles, no lab visits, no waiting. Researchers have built a handheld detector that reads a chemical in breath tied to ketone production from fat, connected to a smartphone.
Fat metabolism produces a byproduct called acetone, the same chemical found in nail polish remover, in trace amounts naturally present in exhaled breath. When the body runs low on carbohydrates, from exercise, fasting, or a low-carb diet, it ramps up ketone production, and acetone levels climb as a result. Measuring it accurately used to require bulky, expensive lab equipment. This new device, small enough to hold in one hand, aims to bring that capability to the kitchen counter.
Researchers at ETH Zurich and the University Hospital Zurich tested the detector across 312 breath samples from 12 volunteers, during exercise sessions, a ketogenic meal protocol, fasting, and a three-week diet intervention moving participants through habitual eating, a ketogenic diet, and intermittent fasting, in that fixed order. The findings, published in the journal Device, showed readings that lined up closely with a high-end mass spectrometer used as a laboratory reference.
The Device Detects Acetone Levels Too Faint to Notice
Blood ketone tests measure a related compound but require a finger prick, while breath sampling is non-invasive and repeatable throughout the day. The challenge has been building something sensitive enough to catch faint traces of acetone in breath nearly as humid as steam, without losing accuracy over time.
A built-in filter strips out moisture and interfering chemicals before the sample reaches the sensor, delivering a reading in about a minute and a half rather than continuous, moment-to-moment monitoring. It held steady across a wide range of humidity levels, with only a small error at the highest levels tested. In an eight-month test, one unit kept giving consistent results day after day with no sign of drifting off, which matters for something meant to sit on a counter for months rather than survive a single lab demo.
Acetone Rose and Fell With Exercise, Fasting, and Diet
Twelve healthy adults, ages 20 to 37, took part: five completed exercise protocols and three followed the dietary plan.
For the exercise portion, volunteers fasted overnight, then ran at varying intensities followed by different meals: carbohydrate-heavy, ketogenic, or none. Breath acetone was measured with both instruments.
After low-intensity exercise and a carbohydrate-rich meal, breath acetone stayed low, a pattern consistent with limited ketone production and greater reliance on carbohydrates. After high-intensity exercise, acetone climbed substantially in the following hours, reaching roughly five times the post-exercise level before dropping after a carbohydrate-rich meal. Fasting or a fat-heavy meal kept levels rising instead. Blood ketone readings followed similar patterns, adding confidence the device was tracking genuine metabolic shifts.
In a separate three-week test, three volunteers checked their breath acetone four times a day through a week of normal eating, a week of strict keto, and a week of intermittent fasting, in that order. Levels stayed low during normal eating, spiked once keto began, and settled back down once fasting started, though how high each person’s numbers climbed varied a lot from one volunteer to the next. Because the diets always ran in the same sequence, it’s hard to say how much of the fasting-phase drop was really about fasting versus the body settling down after two weeks of keto.
Across all 312 samples, the handheld readings matched the lab instrument’s numbers closely and consistently.
A Smartphone App Guides Users to Consistent Breath Samples
Breath composition changes throughout a single exhale, and air from the very end most accurately reflects what’s in the blood. Getting a consistent sample without lab supervision is tricky, so the app shows real-time feedback: a circle expands or contracts with exhalation pressure, with alerts if pressure runs too high or low. Before someone’s first use, the device also measures how much air their lungs can hold, so it knows exactly when to grab the sample during each breath. Five consecutive samples from one person produced readings varying by only about 3%, which suggests the guided process works even without a technician standing over someone’s shoulder.
Results sync to the app, where meals and exercise can be logged alongside readings. One author is an employee and shareholder of Alivion AG, another is a shareholder and advisory-board member, and ETH Zurich holds a patent on the technology; the device was later commercialized as Nutrion.
Devices tracking blood sugar continuously have already transformed diabetes care, letting people see in real time how food and exercise move their numbers. A practical tool for tracking fat-metabolism shifts could eventually complement that kind of monitoring in nutritional, research, or clinical settings, though that role remains untested here. This study measured device accuracy, not whether using it changes weight, athletic performance, or diabetes outcomes. The cohort was small and limited to healthy adults, so broader testing across more diverse groups is needed before anyone should treat this as a clinical tool.
Disclaimer: This article is based on findings from a peer-reviewed study and is intended for general informational purposes only. It is not medical advice. Anyone considering a ketogenic diet, intermittent fasting, or changes to how they monitor their metabolism should speak with a qualified healthcare provider first.
Paper Notes
Limitations
Researchers acknowledged that the study cohort was limited in size and composed entirely of healthy adults aged 20 to 37, with individual acetone responses varying widely between participants. A larger and more diverse group would be needed for clinical validation and to understand device performance in specific patient populations, such as those with obesity, diabetes, or other metabolic conditions. The three-week dietary intervention followed a fixed, non-randomized sequence (habitual diet, then ketogenic diet, then intermittent fasting), so carryover effects between phases cannot be fully separated from the effects of fasting itself. The paper also noted that the activated carbon filter may need more frequent replacement in environments with high concentrations of airborne chemicals. High exogenous ethanol concentrations, for example following alcohol consumption, fall outside the device’s intended operating conditions and are flagged as invalid readings. Weekend measurements during the dietary intervention relied on the most recent weekday calibration rather than same-day calibration, a minor methodological limitation noted by the authors.
Funding and Disclosures
This study was financially supported primarily by Innosuisse (Innovation Project 109.063 IP-LS), the Vontobel-Stiftung (1413/2022), Stiftung Accentus Fonds Thimonia, and Verena Guggisberg-Lüthi, and partially by the Swiss State Secretariat for Education, Research and Innovation (SERI) under contract number MB22.00041, as well as Dr. Angela-Reiffer Stiftung, Fondation Sana (GF 2023-0001), and Iten-Kohaut-Stiftung. Jan van den Broek is an employee and shareholder of Alivion AG, a spin-off company from ETH Zurich. Andreas T. Güntner is a shareholder and member of the advisory board of Alivion AG. ETH Zurich holds a patent on the described technology. Following this study, the detector was commercialized by Alivion AG as Nutrion.
Publication Details
Authors: Simone Hersberger, Jan van den Broek, Lara Schmid, Fabienne Kappeler, Philipp A. Gerber, and Andreas T. Güntner | Affiliations: Human-centered Sensing Laboratory, Department of Mechanical and Process Engineering, ETH Zurich; Alivion AG; Department of Endocrinology, Diabetes, and Clinical Nutrition, University Hospital Zurich | Journal: Device | Volume/Issue: Device 4, 101226, October 16, 2026 | Paper Title: Self-monitoring of fat metabolic status with smartphone-assisted breath acetone detector | DOI: https://doi.org/10.1016/j.device.2026.101226 | Ethics Approval: ETH Zurich Ethics Committee (24 ETHICS-335, approved October 29, 2024)







